Crossmark

Comparing the diagnostic value of targeted with metagenomic next-generation sequencing in immunocompromised patients with lower respiratory tract infection

Crossref DOI link: https://doi.org/10.1186/s12941-024-00749-5

Published Online: 2024-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Muyun

Mao, Shaowei

Li, Shuangshuang

Gu, Kangyi

Gu, Dejian

Bai, Shengjie

Lu, Xinhua

Li, Min
Funding

Funding for this research was provided by:

Yangfan Project of Science and Technology Commission of Shanghai Municipality (23YF1431300)

National Key Research and Development Program (2022YFC2603800)

3-Year Action Plan for Strengthening Public Health System in Shanghai (GWVI-11.1-1)
License Information

Text and Data Mining valid from 2024-09-30

Version of Record valid from 2024-09-30
More Information

Article History

Received: 27 April 2024

Accepted: 20 September 2024

First Online: 30 September 2024

Declarations

:

: This study was conducted in accordance with the ethical guidelines provided by the Declaration of Helsinki and was approved by the Ethics Committee of Renji Hospital, with the approval number KY2023-109-C. The written informed consent from participants was waived and the data were analyzed anonymously.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below